Skip to main content
Monday, November 16, 2026Nov 16

Unsealed lawsuit: Opioid firm placed profits over people

The rosy economy offers oportunities to fix or work on social issues, such as the proliferation of opioidsr.
The rosy economy offers oportunities to fix or work on social issues, such as the proliferation of opioidsr.

NASHVILLE, Tenn. (AP) – A newly unsealed lawsuit by Tennessee’s attorney general says the maker of the world’s top-selling painkiller directed its salesforce to target the highest prescribers, many with limited or no pain management background or training.

Citing the public’s right to know, Attorney General Herbert Slatery said Thursday that OxyContin maker Purdue Pharma has dropped its previous efforts to shield details of the 274-page lawsuit in state court. The Tennessee Coalition for Open Government and the Knoxville News Sentinel had also requested that the lawsuit’s records become public.

The lawsuit says Perdue violated a 2007 settlement with the state, placing profits over people with a deceptive narrative that claimed its opioids were safer than they actually were. The lawsuit also says the Stamford, Connecticut-based company targeted vulnerable people, including the elderly.

Purdue did so while relying on continued users and high doses, according to the lawsuit: 104.3 million OxyContin tablets were prescribed in Tennessee from 2008 to 2017, with 53.7 percent of them 40 milligrams or higher. And more than 80 percent of Purdue’s business consistently came from continued users, the lawsuit says.

For example, Purdue called on two providers 48 times after law enforcement told Purdue the pair was responsible for significant interstate OxyContin diversion, the lawsuit says. The company called on another provider 31 times after the provider’s license was place on restrictive probation related to high-prescribing of controlled substances, the lawsuit adds.